353 related articles for article (PubMed ID: 10224355)
21. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
[TBL] [Abstract][Full Text] [Related]
22. Human IgE against the major allergen Bet v 1--defining an epitope with limited cross-reactivity between different PR-10 family proteins.
Levin M; Davies AM; Liljekvist M; Carlsson F; Gould HJ; Sutton BJ; Ohlin M
Clin Exp Allergy; 2014 Feb; 44(2):288-99. PubMed ID: 24447087
[TBL] [Abstract][Full Text] [Related]
23. Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2.
Ferreira FD; Mayer P; Sperr WR; Valent P; Seiberler S; Ebner C; Liehl E; Scheiner O; Kraft D; Valenta R
J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):95-103. PubMed ID: 8568143
[TBL] [Abstract][Full Text] [Related]
24. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE.
Reginald K; Eckl-Dorna J; Zafred D; Focke-Tejkl M; Lupinek C; Niederberger V; Keller W; Valenta R
Immunol Cell Biol; 2013 Feb; 91(2):167-72. PubMed ID: 23229638
[TBL] [Abstract][Full Text] [Related]
25. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
26. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
[TBL] [Abstract][Full Text] [Related]
27. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
Pauli G; Purohit A; Oster JP; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Clin Exp Allergy; 2000 Aug; 30(8):1076-84. PubMed ID: 10931114
[TBL] [Abstract][Full Text] [Related]
28. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.
Husslik F; Hanschmann KM; Krämer A; Seutter von Loetzen C; Schweimer K; Bellinghausen I; Treudler R; Simon JC; Vogel L; Völker E; Randow S; Reuter A; Rösch P; Vieths S; Holzhauser T; Schiller D
PLoS One; 2015; 10(7):e0132956. PubMed ID: 26186356
[TBL] [Abstract][Full Text] [Related]
29. Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization.
Krebitz M; Wiedermann U; Essl D; Steinkellner H; Wagner B; Turpen TH; Ebner C; Scheiner O; Breiteneder H
FASEB J; 2000 Jul; 14(10):1279-88. PubMed ID: 10877820
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
31. A novel dipstick developed for rapid Bet v 1-specific IgE detection: recombinant allergen immobilized via a monoclonal antibody to crystalline bacterial cell-surface layers.
Breitwieser A; Mader C; Schocher I; Hoffmann-Sommergruber K; Aberer W; Scheiner O; Sleytr UB; Sára M
Allergy; 1998 Aug; 53(8):786-93. PubMed ID: 9722228
[TBL] [Abstract][Full Text] [Related]
32. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules.
Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V
Clin Exp Allergy; 2010 Sep; 40(9):1346-52. PubMed ID: 20604801
[TBL] [Abstract][Full Text] [Related]
34. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
[TBL] [Abstract][Full Text] [Related]
35. Determination of allergen specificity by heavy chains in grass pollen allergen-specific IgE antibodies.
Gadermaier E; Flicker S; Lupinek C; Steinberger P; Valenta R
J Allergy Clin Immunol; 2013 Apr; 131(4):1185-93, 1193.e1-6. PubMed ID: 23206656
[TBL] [Abstract][Full Text] [Related]
36. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China.
Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD
J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268
[TBL] [Abstract][Full Text] [Related]
37. Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer.
Campana R; Vrtala S; Maderegger B; Dall'Antonia Y; Zafred D; Blatt K; Herrmann H; Focke-Tejkl M; Swoboda I; Scheiblhofer S; Gieras A; Neubauer A; Keller W; Valent P; Thalhamer J; Spitzauer S; Valenta R
Mol Immunol; 2011 Jan; 48(4):431-41. PubMed ID: 21093057
[TBL] [Abstract][Full Text] [Related]
38. Comparison of immunoglobulin E measurements on IMMULITE and ImmunoCAP in samples consisting of allergen-specific mouse-human chimeric monoclonal antibodies towards allergen extracts and four recombinant allergens.
Szecsi PB; Stender S
Int Arch Allergy Immunol; 2013; 162(2):131-4. PubMed ID: 23921375
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen.
Godnic-Cvar J; Susani M; Breiteneder H; Berger A; Havelec L; Waldhör T; Hirschwehr R; Valenta R; Scheiner O; Rüdiger H; Kraft D; Ebner C
J Allergy Clin Immunol; 1997 Mar; 99(3):354-9. PubMed ID: 9058691
[TBL] [Abstract][Full Text] [Related]
40. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.
Ferreira F; Ebner C; Kramer B; Casari G; Briza P; Kungl AJ; Grimm R; Jahn-Schmid B; Breiteneder H; Kraft D; Breitenbach M; Rheinberger HJ; Scheiner O
FASEB J; 1998 Feb; 12(2):231-42. PubMed ID: 9472988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
